Revolutionizing Early Assessment
of Mild Cognitive Impairment
Witness Change
® Theia is a registered trademark.
Newmanbrain introduces Theia, a non-invasive, objective, and highly
accurate neuroimaging system designed to assess Mild Cognitive Impairment
(MCI) using functional Near-infrared Spectroscopy (fNIRs).
Dementia is a growing public health crisis. Patients with dementia undergo a tragic
and costly journey. Nevertheless, research shows up to half of dementia risk can be
prevented through lifestyle interventions during the Mild Cognitive Impairment
(MCI) stage, a precursor stage to dementia. Yet, MCI remains massively
underdiagnosed (<8%).¹
1 Liu Y, Jun H, Becker AC, Wallick CJ, Mattke S. Detection Rates of Mild Cognitive Impairment in Primary Care for the United States Medicare Population. The Journal of Prevention of Alzheimer’s Disease.¹
Published online January 1, 2023. doi: https://doi.org/10.14283/jpad.2023.131
Theia is a patented technology that enables mass pre-screenings of MCI, offering
a scalable, non-invasive solution to alleviate this growing healthcare crisis and
empower early intervention.
BENEFITS
High accuracy
>90% accuracy in the differentiation of MCI vs normal cognitive aging
Affordable
Competitive test price. Facilitates mass screening for MCI
Fast
AI-powered assessment in <20 min. Instant report generation
Objective
AI-powered assessment. Supports the reproducibility of results accross different sites & clinicians
Easy to use & Accesible
No need for complex training or facilities. Accesible to individuals with diverse educational background.
WHO IT HELPS?
Patients & Families
Literature suggests Theia may offer improved sensitivity/specificity compared to current neuropsychological tests in identifying MCI allowing early interventions. It is also comfortable and does not require scalp gels or full body immobilization in claustrophobic environments.
Healthcare Providers
Theia enables accurate, cost effective MCI pre-screening across diverse clinical settings. It integrates seamlessly with IT systems,and ensures secure data storage and transmission. Reduce patient waiting lists by empowering a wide array of healthcare professionals.
Researchers & Pharma
Theia aids in understanding brain
hemodynamic changes derived
from different clinical interventions
with objective metrics. It also
broadens patient participation
in clinical trials by using simple
arithmetic tasks that require only
basic reading skills.
